MediFind
Condition

Urothelial Cancer

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 80
  • Start Date: August 20, 2020
DS3201 With Ipilimumab in Patients With Metastatic Aggressive Variant Prostate (AVPC), Urothelial (UC), and Renal Cell (RCC) Carcinomas
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 20
  • Start Date: July 28, 2020
Tolerability and Activity of Neoadjuvant Infigratinib, an Inhibitor of FGFR, in Upper Tract Urothelial Carcinoma
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 12
  • Start Date: July 2020
Investigating Marrow Infiltrating Lymphocytes as a Source of Adoptive Cellular Therapy in Renal Cell Carcinoma and Urothelial Carcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 42
  • Start Date: May 21, 2020
A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 20
  • Start Date: March 23, 2020
A Phase II Study of Intermittent Checkpoint Inhibitor Therapy in Patients With Advanced Urothelial Carcinoma